Clinical Trial

Acute Heart Failure With Reduced Ejection Fraction - COngestion Discharge Evaluation

Study acronym: AHF-CODE-R
Recruiting
View on ClinicalTrials.gov →
Summary
The AHF-CODE reduced study is a prospective, non-randomized, monocenter study performed in patients with heart failure with reduced ejection fraction admitted for worsening heart failure. The main objective of the AHF-CODE study is to identify congestion markers (clinical, biological and ultrasound) at the end of hospitalization for acute heart failure that are associated with the risk of all cause death or rehospitalization for acute heart failure within 3 months of hospital discharge.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2020-04-10; most recent amendment 2023-06-02.
Status change: Not Yet Recruiting → Recruiting 2021-01-14
Trial Details
NCT Number NCT04343443
Lead Sponsor Central Hospital, Nancy, France
Conditions Acute Heart Failure
Enrollment 200 participants
Start Date 2020-08-21
Primary Completion 2026-08-21 (estimated)
Study Completion 2028-08-21 (estimated)
Updated on ClinicalTrials.gov 2023-06-05